Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
The Biotech Startups Podcast
Also in Life Sciences
Science
Approved
by Alex Kesin and Matthew Pech
Recently ranked · United States
Last recorded placements from this show’s chart history. These are not current rankings.
Not on the United Kingdom charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Approved, try…
BioCentury This Week
Also in Life Sciences
The Pharma Closeout | Daily Pharmaceutical and Biotech News in 15 Minutes
Also in Life Sciences
Clinical Pharmacology Podcast with Nathan Teuscher
Also in Life Sciences
Cancer Connections
Also in Life Sciences
The New Biology
Also in Life Sciences
Ranking history · United States
Latest daily rankings: Oct 27. New rankings will appear after the next update.
Recent history only — this show has no current ranking on the Science chart. These are recorded positions from the last 14 days, not current rankings.
Position on the Science combined chart over the last 14 days. Toggle platforms to compare their positions. Lower rank numbers are better.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 27 | — | — |
| Oct 21 | — | #192 |
| Oct 20 | #192 | #178 |
| Oct 19 | #178 | #162 |
| Oct 18 | #174 | #158 |
| Oct 17 | #159 | #141 |
| Oct 16 | #123 | #104 |
| Oct 15 | #189 | #173 |
| Oct 14 | #165 | #149 |
Latest episodes
-
Allergan: Botox, Rogue Scientists, and the Ultimate Beauty Franchise
September 18, 2026 · 3 hr 37 minThe wild story of how a Cold War bioweapon became Botox — and how Allergan turned a sleepy ophthalmology drug into an enduring aesthetic franchise. Every part of this story looks nothing like your normal blockbuster drug. Botox started its…
-
What is Approved?
September 14, 2026 · 3 minApproved tells the definitive stories behind the world's most interesting biotech ventures. Most people learn about the industry in a fragmented, ad hoc way-- an industry article here, a clinical trial readout there, some science…
-
Blueprint Medicines: Chasing Gleevec to a $9B Allergy Drug
August 4, 2026 · 2 hr 30 minBlueprint Medicines was built to find the next Gleevec-style cancer drug. It ended up pivoting to allergic disease instead, and selling to Sanofi for $9B. This is the platform, the pivot, and who got paid. Blueprint Medicines set out to be…
-
Keytruda: How Merck's Pembrolizumab Became the Best-Selling Cancer Drug of All Time
May 14, 2026 · 2 hr 8 minKeytruda is Merck's $31 billion a year PD-1 inhibitor and the best-selling cancer drug of all time. In Episode 3 of Approved, Alex Kesin and Matthew Pech trace the development of pembrolizumab , featuring interviews the scientists who…
-
Episode #2: Geron
March 13, 2026 · 2 hr 22 minListen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:01:19) - Hayflick Limit (00:08:30) - Michael West & Founding of Geron (00:15:16) - Early Science & IP Strategy (00:27:25)…
Show 1 more episodeShow fewer episodes
-
Episode #1: Amylin Pharmaceuticals
January 30, 2026 · 1 hr 46 minListen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:04:40) - $50 of Dried Lizard Venom (00:29:17) - Fax of Death (00:43:04) - Sleeping Beauty Awakens (00:52:07) - Carl Icahn Sends a…
About the show
Life sciences, under the hood. Deep dives into the patent filings, regulatory gauntlets, and capital-risks that shape the business of biology.